2010
DOI: 10.1002/ijc.25292
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic use of human alpha‐fetoprotein in clinical patients: Is a cancer risk involved?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2011
2011
2023
2023

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 59 publications
0
19
0
Order By: Relevance
“…Hepatocellular carcinoma (HCC) is the fifth most frequent neoplasm worldwide, and accounts for 5.6% of all human cancers [1][2][3]. There is an increasing incidence of HCC in China, and this neoplasm has become China's second most frequent cause of cancer-related death [4].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Hepatocellular carcinoma (HCC) is the fifth most frequent neoplasm worldwide, and accounts for 5.6% of all human cancers [1][2][3]. There is an increasing incidence of HCC in China, and this neoplasm has become China's second most frequent cause of cancer-related death [4].…”
Section: Discussionmentioning
confidence: 99%
“…Although it has been widely used as a marker in clinical diagnosis, compelling progress made in determining the biological role of AFP has recently attracted considerable interest, as AFP shows a close association with HCC carcinogenesis and the high mortality rate of this tumor [1][2][3]. In addition, there has been increasing focus on the role of AFP in promoting cell growth in cultured cells, and this ''growth factor'' function is yet another intriguing aspect of AFP biology.…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Gang Li and his team following their meticulous studies of the effect of AFP on growth enhancement of human liver cancer cells [40][41][42][43]. It was then demonstrated by Li et al in 2009 that CyAFP played a role in caspase-3-mediated cell signaling affecting apoptosis [44].…”
Section: Cyafp Involvement In Intracellular Signaling and Regulationmentioning
confidence: 95%
“…The cancer risk of using recombinant human AFP as a therapeutic agent has already been addressed by the author [43]. Although AFP is a beneficial growth enhancing agent during pregnancy, full-length AFP may play a lethal role in adults in the initiation of growth, proliferation, and metastasis of human liver cancer.…”
Section: Postscript: a Cancer Warningmentioning
confidence: 99%